Table 2

Regional cerebral blood flow 48 hours post subarachnoid hemorrhage

Control

SAH

SAH + SB386023-b

after 0 hours

SAH + SB386023-b

after 6 hours


frontal cortex

141 ± 16a

75 ± 20a, b

132 ± 17b

135 ± 19b


parietal cortex

169 ± 30a

68 ± 14a, b

141 ± 28b

132 ± 30b


occiptal cortex

137 ± 17a

67 ± 21a, b

141 ± 20b

155 ± 21b


caudate putamen

131 ± 17a

71 ± 20a, b

129 ± 16b

142 ± 18b


Septum

115 ± 24a

60 ± 20a, b

104 ± 18

128 ± 20b


hippocampus

147 ± 25a

52 ± 11a, b

88 ± 13b

85 ± 20b


Thalamus

120 ± 16a

64 ± 16a, b

124 ± 17b

136 ± 15b


Hypothalamus

107 ± 20

55 ± 16b

95 ± 9

127 ± 15b


Corpus callosum

80 ± 19

41 ± 18

57 ± 14

87 ± 14


sensorimotor cortex

164 ± 27

74 ± 20

134 ± 15b

140 ± 17b


superiour colliculus

197 ± 27a

70 ± 20a, b

121 ± 12b

130 ± 17b


inferior colliculus

122 ± 5a

71 ± 19a, b

134 ± 21b

67 ± 21b


cerebellar cortex

127 ± 25a

53 ± 14a, b

116 ± 25b

135 ± 27b


dentate nucleus

133 ± 20a

53 ± 14a, b

127 ± 17b

114 ± 20b


facial nucleus

170 ± 31a

70 ± 21a, b

156 ± 32b

131 ± 30b


cochlear nucleus

150 ± 30a

54 ± 15a, b

150 ± 21b

119 ± 25b


vestibular nucleus

153 ± 18a

75 ± 23a, b

167 ± 22b

130 ± 20b


trigeminal nucleus

154 ± 22a

65 ± 19a, b

149 ± 22b

124 ± 23b


Values are expressed in ml/min/100 g and given as mean ± s.e.m. a = significant difference between SAH and control groups, b = significant difference between SAH and SAH treated with SB386023-b 0 hr and 6 hr post SAH.

Ansar et al. BMC Neuroscience 2011 12:107   doi:10.1186/1471-2202-12-107

Open Data